U.S. Interactive Media and Services Stock News

NYSE:LAD
NYSE:LADSpecialty Retail

How Board Expansion And JPMorgan’s Caution At Lithia Motors (LAD) Has Changed Its Investment Story

In February 2026, Lithia Motors’ board amended its bylaws to remove the upper limit on board size and set the director count at 10 for the 2026 annual shareholder meeting. Around the same time, JPMorgan shifted to a more cautious stance on Lithia Motors, highlighting execution visibility, cost control challenges, and higher balance sheet leverage despite an otherwise constructive industry backdrop. We’ll now examine how JPMorgan’s concerns about execution and cost control may affect Lithia...
NYSE:AGM
NYSE:AGMDiversified Financial

Federal Agricultural Mortgage (AGM) Is Up 5.5% After Dividend Hike Despite Softer Q4 Earnings - Has The Bull Case Changed?

In February 2026, Federal Agricultural Mortgage Corporation reported fourth-quarter 2025 net income of US$47.92 million, down from US$56.51 million a year earlier, while full-year net income was broadly flat at US$207.42 million, and its board approved higher dividends on both common and preferred shares. Beyond the headline earnings softness, Farmer Mac’s fifteenth consecutive annual increase in its common dividend, alongside growth in infrastructure finance such as broadband and renewable...
NYSE:MANU
NYSE:MANUEntertainment

Did Cost-Cut-Driven Q2 Profit and Reaffirmed Guidance Just Shift Manchester United's (MANU) Investment Narrative?

Manchester United plc has reported fiscal second-quarter 2026 results, with sales of £190.31 million and a net income of £4.18 million, marking a return to profit despite lower revenue than the same period a year ago. The earnings improvement stems largely from cost and headcount reductions that turned a prior-period loss into a profit, while management reiterated full-year revenue guidance of £640 million to £660 million. We’ll now look at how this cost-driven profitability turnaround,...
NYSE:GTLS
NYSE:GTLSMachinery

Assessing Chart Industries (GTLS) Valuation After Fourth Quarter Earnings Miss

Why Chart Industries’ latest earnings matter for shareholders Chart Industries (GTLS) just released fourth quarter and full year 2025 results, with both net income and sales below the prior year and revenue and earnings missing Wall Street forecasts. See our latest analysis for Chart Industries. At a share price of $207.30, Chart Industries has seen relatively steady recent trading, with a 90 day share price return of 1.60% and a 1 year total shareholder return of 8.79%. This suggests that...
NasdaqGS:INNV
NasdaqGS:INNVHealthcare

A Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating

Analysts have recently raised their earnings estimates for InnovAge Holding (INNV) for both the current quarter and full year. This shift in expectations appears to be a key catalyst for the stock. See our latest analysis for InnovAge Holding. The recent upward revisions to earnings expectations come after a sharp run in the shares, with a 30 day share price return of 61.44% and a 1 year total shareholder return of 175.69%. This suggests momentum has recently picked up despite a weaker 5 year...
NYSE:SPB
NYSE:SPBHousehold Products

Is Spectrum Brands Holdings (SPB) Still Attractive After Its Sharp Recent Share Price Rally

If you are wondering whether Spectrum Brands Holdings is still attractively priced or already reflecting its potential, you are in the right place for a clear, valuation focused look at the stock. The share price recently closed at US$78.38, with returns of 23.0% over 30 days and 30.5% year to date, while the 1 year return sits at 4.4% and the 3 and 5 year returns are 28.8% and 8.8% respectively. This naturally raises questions about how much value is already priced in. Recent news around...
NYSE:AVA
NYSE:AVAIntegrated Utilities

Assessing Avista (AVA) Valuation After Earnings Growth, Dividend Hike And New Clean Energy Projects

Avista (AVA) just posted its full year 2025 results, reporting higher earnings, a 24th consecutive annual dividend increase to US$1.97 per share, and updated guidance along with regulatory and project developments that drew investor attention. See our latest analysis for Avista. At a share price of US$40.62, Avista has seen a 1 day share price return of 2.14% and a year to date share price return of 4.91%. Its 1 year total shareholder return of 6.78% and 5 year total shareholder return of...
NYSE:CMC
NYSE:CMCMetals and Mining

Assessing Commercial Metals (CMC) Valuation As Earnings, Acquisitions And Margin Program Draw Focus

Commercial Metals (CMC) is drawing fresh attention as it heads into its fiscal Q2 2026 earnings release and webcasted conference call, following two recent concrete products acquisitions. See our latest analysis for Commercial Metals. Recent trading has cooled after a strong run, with a 1 day share price return of 2.15% decline and a 30 day share price return of 5.98% decline. However, the 1 year total shareholder return of 53.28% and 5 year total shareholder return of 173.11% point to...
NYSE:FE
NYSE:FEElectric Utilities

The Bull Case For FirstEnergy (FE) Could Change Following 2025 Results And New US$36B Grid Plan

FirstEnergy Corp. has reported its 2025 results, with revenue rising to US$15.09 billion and net income reaching US$1.02 billion, alongside modestly higher earnings per share from continuing operations. At the same time, the company unveiled its Energize365 program, a US$36 billion capital plan for 2026–2030 that heavily prioritizes transmission upgrades and grid resilience, aiming to support long-term value creation. Next, we'll examine how this expanded US$36 billion Energize365 investment...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV) Is Down 42.1% After Launching $75 Million Buyback Amid Ongoing Losses - What's Changed

Claritev Corporation recently reported past fourth-quarter 2025 sales of US$246.55 million and a net loss of US$80.57 million, alongside full-year 2025 sales of US$965.41 million and a net loss of US$284.28 million, and announced a new share repurchase program of up to US$75 million running through 2030. While the company remains loss-making, the year-on-year reduction in losses and the commitment to buying back shares suggest management is focused on improving financial discipline and...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

Assessing Perdoceo Education’s (PRDO) Valuation After Earnings Growth Guidance And Dividend Affirmation

Perdoceo Education (PRDO) drew fresh attention after reporting fourth quarter and full year 2025 earnings, issuing new 2026 guidance, and affirming its quarterly dividend, giving investors several data points to reassess the stock. See our latest analysis for Perdoceo Education. The recent earnings, 2026 guidance and dividend affirmation come after a period of steady share price strength, with a 90 day share price return of 19.83% and a 1 year total shareholder return of 32.10% supporting a...
NYSE:UCB
NYSE:UCBBanks

Assessing Whether United Community Banks (UCB) Still Looks Undervalued After Recent Share Price Weakness

Without a specific news announcement driving attention today, United Community Banks (UCB) still offers investors concrete data points to consider, including recent share performance, profitability metrics, and value-focused scores. See our latest analysis for United Community Banks. At a share price of $32.17, United Community Banks has seen a 6.56% 1 month share price decline, while its 90 day share price return of 3.91% and 1 year total shareholder return of 3.10% point to relatively...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Valuation Check As iDose Sales Momentum Meets Impairment Charge And Upbeat 2026 Outlook

Glaukos (GKOS) is back in focus after its fourth quarter 2025 report paired strong sales figures with a sizeable impairment charge, followed shortly by fresh 2026 sales guidance and a new ESOP related shelf registration. See our latest analysis for Glaukos. The recent impairment charge and ESOP related shelf registration come against a backdrop of steady share price gains, with a 90 day share price return of 13.28% and a very large 3 year total shareholder return of 139.03%. This suggests...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

Xeris Biopharma Holdings (XERS) Is Down 7.4% After Suing to Block Recorlev Generics Until 2040

Xeris Biopharma recently filed a Hatch-Waxman patent infringement lawsuit in the US District Court for the District of New Jersey against Torrent Pharmaceuticals and Somerset Therapeutics, seeking to block generic versions of its Cushing’s syndrome therapy Recorlev until its patents expire in March 2040. This legal move highlights how central Recorlev’s intellectual property protection is to Xeris’s long-term product exclusivity and potential revenue longevity in its endocrine...
NYSE:SEE
NYSE:SEEPackaging

Assessing Sealed Air (SEE) Valuation As Shares Trade Near Recent Levels

Why Sealed Air is on investors’ radar today Sealed Air (SEE) is back in focus after recent trading left the shares around $41.88, prompting investors to reassess how its packaging business and current valuation line up with their expectations. See our latest analysis for Sealed Air. While the 1-day and 7-day share price returns are slightly negative, Sealed Air’s 1-year total shareholder return of 25.46% contrasts with weaker 3-year and modest 5-year total shareholder returns, which suggests...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is EyePoint (EYPT) Recasting Its Ophthalmology Playbook With a Veteran Launch Executive at DURAVYU?

EyePoint, Inc. recently appointed Michael Campbell as Chief Commercial Officer, giving him responsibility for commercial strategy and launch preparation for DURAVYU, its Phase 3 retinal disease candidate. The hire brings in a leader who helped shape the commercial playbooks behind Lucentis, Xiidra, Beovu and Tyrvaya, directly relevant to DURAVYU’s target markets. We’ll now examine how adding a veteran ophthalmology launch executive to oversee DURAVYU’s commercialization may influence...
NYSE:EMR
NYSE:EMRElectrical

Emerson Electric (EMR) Valuation Check After Q1 2026 Beat And Raised EPS Outlook

Emerson Electric (EMR) is back on investors’ radar after its Q1 2026 earnings report and a higher full year EPS forecast, with management pointing to electrification and nearshoring as key demand drivers. See our latest analysis for Emerson Electric. The Q1 earnings beat and raised EPS guidance arrived after a strong run, with a 90 day share price return of 14.26% and a 1 year total shareholder return of 26.02%, suggesting momentum has been building over both shorter and longer periods. If...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors?

Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its drug diversion detection capabilities and recurring revenue base. This pivot toward subscription-like revenue streams is prompting investors to reassess Omnicell less as a traditional equipment maker and more as a healthcare IT provider, with different expectations for growth, risk and valuation. Next, we’ll examine how Omnicell’s...
NYSE:ENS
NYSE:ENSElectrical

What EnerSys (ENS)'s New Mid‑Cap Fund Backing and Buyback Focus Means For Shareholders

In Q4 2025, Harbor Capital Advisors' Mid Cap Value Fund disclosed that it had initiated a new position in EnerSys, citing improving operating margins, sales growth, strong cash flow, ongoing share buybacks, and regular dividend payments as key reasons for the investment. The fund also ranked EnerSys in the top 5% of its evaluation universe, highlighting how the company’s combination of operating momentum and capital returns screens well against a broad mid-cap peer group. Next, we’ll examine...
NasdaqGS:VLY
NasdaqGS:VLYBanks

A Look At Valley National Bancorp (VLY) Valuation After Inflation Jitters And Credit Risk Concerns

Valley National Bancorp (VLY) shares dropped 6.2% as hotter inflation data and growing credit risk worries pressured regional lenders, even though the bank confirmed regular dividends and a new share repurchase authorization. See our latest analysis for Valley National Bancorp. Despite the latest 5.7% one day share price decline to US$12.61, Valley National Bancorp’s 90 day share price return of 9.8% and 1 year total shareholder return of 34.0% suggest momentum has generally been positive...
NYSE:ACA
NYSE:ACAConstruction

Assessing Arcosa (ACA) Valuation After Recent Share Pullback And Conflicting Fair Value Signals

Arcosa (ACA) is back on investors’ radar after a recent share pullback over the past week and month, drawing attention to how its infrastructure focused business and current valuation metrics stack up today. See our latest analysis for Arcosa. The sharp 1 day share price decline of 15.7% and 7 day share price return of 14.9% sit against a 1 year total shareholder return of 28.42% and 5 year total shareholder return of 84.39%. This suggests recent momentum has cooled after a strong multi year...
NYSE:LADR
NYSE:LADRMortgage REITs

How Ladder’s New US$1.25 Billion Unsecured Facility And Term Loan At Ladder Capital (LADR) Has Changed Its Investment Story

In February 2026, Ladder Capital Corp. announced it had secured US$675 million in new unsecured capital commitments, expanding its unsecured revolving credit facility to US$1.25 billion and adding a US$275 million unsecured delayed draw term loan priced at 140 basis points over SOFR. This package of same-day liquidity at 125 basis points over SOFR and long-dated funding to 2030 materially strengthens Ladder’s funding flexibility and duration profile. Next, we’ll examine how this expanded...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

Regency Centers Note Sale Sparks Fresh Questions On Debt And Valuation

Regency Centers completed a public offering of $450 million in senior unsecured notes due 2033. The issuance is intended to support balance sheet optimization and ongoing development activities. The company trades on the NasdaqGS under the ticker NasdaqGS:REG, with a current share price of $79.0. For investors watching NasdaqGS:REG, this $450 million notes offering is a fresh data point on how Regency Centers is managing its capital structure. The stock is at $79.0, with returns of 2.8%...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

A Look At LPL Financial Holdings (LPLA) Valuation After Recent Share Price Weakness

LPL Financial Holdings (LPLA) has drawn attention after a period of weaker share performance, with returns over the past month, past 3 months, and year all in negative territory, even though multi year total returns remain positive. See our latest analysis for LPL Financial Holdings. The recent 1 month share price return of a 17.59% decline and year to date share price return of a 16.94% decline point to fading near term momentum, even though the 5 year total shareholder return of 129.88%...